Checkpoint Therapeutics, Inc. (CKPT)
NASDAQ: CKPT · Real-Time Price · USD
3.130
-0.050 (-1.57%)
At close: Feb 21, 2025, 4:00 PM
3.110
-0.020 (-0.64%)
After-hours: Feb 21, 2025, 4:22 PM EST
Checkpoint Therapeutics Employees
Checkpoint Therapeutics had 23 employees as of December 31, 2023. The number of employees decreased by 1 or -4.17% compared to the previous year.
Employees
23
Change (1Y)
-1
Growth (1Y)
-4.17%
Revenue / Employee
$2,043
Profits / Employee
-$2,020,348
Market Cap
152.85M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
CKPT News
- 2 months ago - Checkpoint Therapeutics: Updating My Strategy After Unloxcyt's Approval - Seeking Alpha
- 2 months ago - Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT™ (cosibelimab-ipdl) - GlobeNewsWire
- 3 months ago - Checkpoint Therapeutics: Preparing For Cosibelimab's Upcoming PDUFA Date - Seeking Alpha
- 3 months ago - Checkpoint Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 5 months ago - Checkpoint Therapeutics Announces Cosibelimab Longer-Term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ESMO Congress 2024 - GlobeNewsWire
- 6 months ago - Checkpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 6 months ago - Checkpoint Therapeutics: A Binary Bet On FDA Approval And Cosibelimab's Market Success - Seeking Alpha
- 6 months ago - Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates - GlobeNewsWire